Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Integr Neurosci ; 21(1): 8, 2022 Jan 28.
Article in English | MEDLINE | ID: mdl-35164444

ABSTRACT

We report on our remote speech therapy experience in post-stroke aphasia. The aim was to test the feasibility and utility of telerehabilitation to support future randomized controlled trials. Post-stroke aphasia is a common and disabling speech disorder, which significantly affects patients' and caregivers' health and quality of life. Due to COVID-19 pandemic, most of the conventional speech therapy approaches had to stop or "switch" into telerehabilitation procedures to ensure the safety of patients and operators but, concomitantly, the best rehabilitation level possible. Here, we planned a 5-month telespeech therapy programme, twice per week, of a patient with non-fluent aphasia following an intracerebral haemorrhage. Overall, treatment adherence based on the operator's assessments was high, and incomplete adherence for technical problems occurred very rarely. In line with the patient's feedback, acceptability was also positive, since he was constantly motivated during the sessions and the exercises performed autonomously, as confirmed by the speech therapist and caregiver, respectively. Moreover, despite the sequelae from the cerebrovascular event, evident in some writing tests due to the motor deficits in his right arm and the disadvantages typical of all telepractices, more relevant results were achieved during the telerehabilitation period compared to those of the "face-to-face" therapy before the COVID-19 outbreak. The telespeech therapy performed can be considered successful and the patient was able to return to work. Concluding, we support it as a feasible approach offering patients and their families the opportunity to continue the speech and language rehabilitation pathway, even at the time of pandemic.


Subject(s)
Aphasia/rehabilitation , Stroke Rehabilitation/methods , Stroke/complications , Telerehabilitation , Aphasia/etiology , COVID-19 , Humans , Language Therapy/methods , Male , Middle Aged , Pandemics , Speech Therapy/methods , Treatment Outcome
2.
Ther Adv Neurol Disord ; 11: 1756286418759973, 2018.
Article in English | MEDLINE | ID: mdl-29511386

ABSTRACT

BACKGROUND: Based on the hyperexcitability and disinhibition observed in patients with restless legs syndrome (RLS) following transcranial magnetic stimulation (TMS), we conducted a study with low-frequency repetitive TMS (rTMS) over the primary motor (M1) and somatosensory cortical areas (S1) in patients with RLS. METHODS: A total of 13 right-handed patients and 10 age-matched controls were studied using clinical scales and TMS. Measurements included resting motor threshold (rMT), motor-evoked potentials (MEPs), cortical silent period (CSP), and central motor conduction time (CMCT). A single evening session of rTMS (1 Hz, 20 trains, 50 stimuli each) was administered over the left M1, left S1, and sham stimulation over M1 in a random order. Clinical and TMS measures were repeated after each stimulation modality. RESULTS: Baseline CSP was shorter in patients than in controls and remained shorter in patients for both motor and somatosensory stimulation. The patients reported a subjective improvement of both initiating and maintaining sleep the night after the rTMS over S1. Patients exhibited a decrease in rMT after rTMS of S1 only, although the effect was smaller than in controls. MEP latency and CMCT changed only in controls after stimulation. Sham stimulation was without effect on the observed variables. CONCLUSIONS: rTMS on S1-M1 connectivity alleviated the sensory-motor complaints of RLS patients. The TMS indexes of excitation and inhibition indicate an intracortical and corticospinal imbalance, mainly involving gamma-aminobutyric acid (GABA)ergic and glutamatergic circuitries, as well as an impairment of the short-term mechanisms of cortical plasticity. The rTMS-induced activation of the dorsal striatum with the consequent increase of dopamine release may have contributed to the clinical and neurophysiological outcome.

3.
J Stroke Cerebrovasc Dis ; 23(5): e379-81, 2014.
Article in English | MEDLINE | ID: mdl-24656241

ABSTRACT

BACKGROUND: Vascular progressive supranuclear palsy (vPSP) is an uncommon akinetic-rigid syndrome characterized by asymmetric lower body involvement, predominant corticospinal and pseudobulbar signs, urinary incontinence, cognitive impairment, and increased frequency of stroke risk factors, together with neuroimaging evidence of vascular disease. CASE REPORT: We report a case of a patient with a PSP-like phenotype and marked cognitive impairment who significantly worsened after a generalized epileptic seizure that occurred a few months after its clinical onset. RESULTS: Signs of widespread ischemic subcortical vascular disease, together with atrophy of the midbrain tectum, corpus callosum, and cerebral cortex, were evident on brain magnetic resonance imaging. CONCLUSIONS: vPSP is a condition that should be considered when a patient presents with a gradually progressive clinical picture suggestive of idiopathic PSP associated with neuroimaging evidence of cerebrovascular disease. The occurrence of epileptic seizures has not been reported before in vPSP but they might trigger the onset or precipitate the course of the PSP-like disorders.


Subject(s)
Cerebrovascular Disorders/complications , Epilepsy/complications , Supranuclear Palsy, Progressive/complications , Aged , Anticonvulsants/therapeutic use , Antiparkinson Agents/therapeutic use , Brain/pathology , Brain/physiopathology , Cerebrovascular Disorders/diagnosis , Cerebrovascular Disorders/drug therapy , Cerebrovascular Disorders/physiopathology , Cerebrovascular Disorders/psychology , Cognition , Disease Progression , Epilepsy/diagnosis , Epilepsy/drug therapy , Epilepsy/physiopathology , Epilepsy/psychology , Humans , Magnetic Resonance Imaging , Male , Phenotype , Risk Factors , Supranuclear Palsy, Progressive/diagnosis , Supranuclear Palsy, Progressive/drug therapy , Supranuclear Palsy, Progressive/physiopathology , Supranuclear Palsy, Progressive/psychology , Treatment Outcome
4.
Sleep Med ; 10(3): 312-6, 2009 Mar.
Article in English | MEDLINE | ID: mdl-18753001

ABSTRACT

OBJECTIVE: The purpose of this study was to detect the eventual presence of a minor voluntary motor involvement in restless legs syndrome (RLS), not detectable clinically, which might be observed by means of a sophisticated instrumental analysis of movement, such as gait analysis. SUBJECTS AND METHODS: Gait analysis was performed and surface EMG activity was recorded in 13 RLS patients and 8 normal controls from 8 muscles: tibialis anterior, gastrocnemius lateralis, gastrocnemius medialis, and soleus in both legs. RESULTS: Ten out of the 13 RLS patients and none of the normal control group showed a mild abnormality of the EMG activation of the gastrocnemius muscles during gait which, however, had no detectable effects on its kinematics. CONCLUSIONS: These preliminary results might be interpreted as the effect of an impaired supraspinal dopaminergic control with possible action on spinal structures involved in the control of gait. If confirmed in future studies, this mild EMG abnormality might constitute an additional supportive feature for the diagnosis of RLS in difficult cases.


Subject(s)
Electromyography/methods , Gait/physiology , Muscle, Skeletal/physiology , Restless Legs Syndrome/diagnosis , Restless Legs Syndrome/physiopathology , Adult , Biomechanical Phenomena , Dopamine/physiology , Electromyography/instrumentation , Female , Humans , Male , Middle Aged , Pilot Projects , Volition/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...